Effect of nitric oxide donor nitroglycerin on bone mineral density in a rat model of estrogen deficiency-induced osteopenia

被引:71
作者
Hukkanen, M
Platts, LAM
Lawes, T
Girgis, SI
Konttinen, YT
Goodship, AE
MacIntyre, I
Polak, JM
机构
[1] Univ Helsinki, Biomedicum Helsinki, Inst Biomed Anat, FIN-00014 Helsinki, Finland
[2] ORTON Res Inst, Helsinki, Finland
[3] Invalid Fdn, Orthopaed Hosp, Helsinki, Finland
[4] Univ London, Chelsea & Westminster Hosp, Imperial Coll Sch Med, Tissue Engn Ctr, London, England
[5] Univ London Royal Vet Coll, Hatfield, Herts, England
[6] Univ London, Imperial Coll Sch Med, Dept Chem Pathol, London, England
[7] Univ Helsinki, Cent Hosp, Dept Med Invartes Med, Helsinki, Finland
[8] Univ London Queen Mary & Westfield Coll, St Bartholomews & Royal London Sch Med & Dent, William Harvey Res Inst, London E1 4NS, England
基金
英国惠康基金; 芬兰科学院;
关键词
bone mineral density; estrogen; nitroglycerin; nitric oxide; torsional stiffness; torsional strength;
D O I
10.1016/S8756-3282(02)00955-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Nitric oxide (NO) may modulate estrogen's anabolic effects on bone homeostasis by restraining osteoclast-mediated bone resorption and stimulation of osteoblast activity. Accordingly, NO donated by organic nitrates, including nitroglycerin, is thought to protect against bone loss associated with estrogen deficiency. In this study, we have explored this phenomenon. Thirty-two 12-week-old female Wistar rats were divided into four groups prior to bilateral ovariectomy or a sham operation. The ovariectomised rats received (1) vehicle control (OVX control), (2) 17-beta-estradiol (OVX+E2), or (3) transdermal nitroglycerin (OVX+NG) for 4 weeks. Femoral and tibia] bone mineral density (BMD), serum alkaline phosphatase and urine deoxypyridinoline and NO metabolites were analysed at the end of the study period together with failure torque and torsional rigidity of the tibiae and cellular localisation of the NO-synthase (NOS) isoforms. In OVX+E2 group, proximal and distal femoral and proximal tibia] BMD exceeded that of the Sham controls. Nitroglycerin prevented BMD loss at these three sites at levels comparable to that of the Sham controls. Deoxypyridinoline excretion did not change except in the OVX-E2 group that showed an expected reduction when compared to the Sham and OVX controls. There were no treatment-related differences in total alkaline phosphatase or urinary NO metabolites. Tibia] failure torque was comparable between the groups but both OVX+E2 and OVX+NG groups showed decreased torsional rigidity compared with the OVX controls. Endothelial and inducible NOS were found in osteoblast-like cells associated with calcifying cartilage spicules in the distal femoral metaphysis. These data confirm previous findings and show that nitroglycerin counteracts the estrogen deficiency-induced osteopenia in the ovariectomised rat model. Organic nitrates may thus be beneficial in conditions where bone turnover is compromised such as in osteoporosis. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:142 / 149
页数:8
相关论文
共 33 条
[1]   Effect of 1 alpha-vitamin D-3 and estrogen therapy on cortical bone mechanical properties in the ovariectomized rat model [J].
Aerssens, J ;
VanAudekercke, R ;
Talalaj, M ;
Geusens, P ;
Bramm, E ;
Dequeker, J .
ENDOCRINOLOGY, 1996, 137 (04) :1358-1364
[2]   Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity [J].
Aguirre, J ;
Buttery, L ;
O'Shaughnessy, M ;
Afzal, F ;
de Marticorena, IF ;
Hukkanen, M ;
Huang, P ;
MacIntyre, I ;
Polak, J .
AMERICAN JOURNAL OF PATHOLOGY, 2001, 158 (01) :247-257
[3]   Estrogen upregulates endothelial constitutive nitric oxide synthase expression in human osteoblast-like cells [J].
Armour, KE ;
Ralston, SH .
ENDOCRINOLOGY, 1998, 139 (02) :799-802
[4]   Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase [J].
Armour, KE ;
Armour, KJ ;
Gallagher, ME ;
Gödecke, A ;
Helfrich, MH ;
Reid, DM ;
Ralston, SH .
ENDOCRINOLOGY, 2001, 142 (02) :760-766
[5]   BIDIRECTIONAL REGULATION OF OSTEOCLAST FUNCTION BY NITRIC-OXIDE SYNTHASE ISOFORMS [J].
BRANDI, ML ;
HUKKANEN, M ;
UMEDA, T ;
MORADIBIDHENDI, N ;
BIANCHI, S ;
GROSS, SS ;
POLAK, JM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2954-2958
[6]   Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women [J].
Cicinelli, E ;
Ignarro, LJ ;
Lograno, M ;
Matteo, G ;
Falco, N ;
Schonauer, LM .
FERTILITY AND STERILITY, 1997, 67 (01) :63-66
[7]   Effects of short-term transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women [J].
Cicinelli, E ;
Ignarro, LJ ;
Schönauer, LM ;
Matteo, MG ;
Galantino, P ;
Balzano, G .
FERTILITY AND STERILITY, 1998, 69 (01) :58-61
[8]   Circulating levels of nitric oxide in fertile women in relation to the menstrual cycle [J].
Cicinelli, E ;
Ignarro, LJ ;
Lograno, M ;
Galantino, P ;
Balzano, G ;
Schonauer, LM .
FERTILITY AND STERILITY, 1996, 66 (06) :1036-1038
[9]  
Corbett SA, 1999, CLIN ORTHOP RELAT R, P247
[10]   Nitric oxide in fracture repair - Differential localisation, expression and activity of nitric oxide synthases [J].
Corbett, SA ;
Hukkranen, M ;
Batten, J ;
McCarthy, ID ;
Polak, JM ;
Hughes, SPF .
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME, 1999, 81B (03) :531-537